These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24411709)

  • 1. Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial.
    Haïk S; Marcon G; Mallet A; Tettamanti M; Welaratne A; Giaccone G; Azimi S; Pietrini V; Fabreguettes JR; Imperiale D; Cesaro P; Buffa C; Aucan C; Lucca U; Peckeu L; Suardi S; Tranchant C; Zerr I; Houillier C; Redaelli V; Vespignani H; Campanella A; Sellal F; Krasnianski A; Seilhean D; Heinemann U; Sedel F; Canovi M; Gobbi M; Di Fede G; Laplanche JL; Pocchiari M; Salmona M; Forloni G; Brandel JP; Tagliavini F
    Lancet Neurol; 2014 Feb; 13(2):150-8. PubMed ID: 24411709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
    van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM
    Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline in early CJD: a double-blinded randomised phase II and observational study.
    Varges D; Manthey H; Heinemann U; Ponto C; Schmitz M; Schulz-Schaeffer WJ; Krasnianski A; Breithaupt M; Fincke F; Kramer K; Friede T; Zerr I
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):119-125. PubMed ID: 27807198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
    Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial.
    de Yebenes JG; Landwehrmeyer B; Squitieri F; Reilmann R; Rosser A; Barker RA; Saft C; Magnet MK; Sword A; Rembratt A; Tedroff J;
    Lancet Neurol; 2011 Dec; 10(12):1049-57. PubMed ID: 22071279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Confavreux C; O'Connor P; Comi G; Freedman MS; Miller AE; Olsson TP; Wolinsky JS; Bagulho T; Delhay JL; Dukovic D; Truffinet P; Kappos L;
    Lancet Neurol; 2014 Mar; 13(3):247-56. PubMed ID: 24461574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.
    Ljøstad U; Skogvoll E; Eikeland R; Midgard R; Skarpaas T; Berg A; Mygland A
    Lancet Neurol; 2008 Aug; 7(8):690-5. PubMed ID: 18567539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
    Leist TP; Comi G; Cree BA; Coyle PK; Freedman MS; Hartung HP; Vermersch P; Casset-Semanaz F; Scaramozza M;
    Lancet Neurol; 2014 Mar; 13(3):257-67. PubMed ID: 24502830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
    Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
    Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
    Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
    Kirschner J; Schessl J; Schara U; Reitter B; Stettner GM; Hobbiebrunken E; Wilichowski E; Bernert G; Weiss S; Stehling F; Wiegand G; Müller-Felber W; Thiele S; Grieben U; von der Hagen M; Lütschg J; Schmoor C; Ihorst G; Korinthenberg R
    Lancet Neurol; 2010 Nov; 9(11):1053-9. PubMed ID: 20801085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Kharfan-Dabaja MA; Boeckh M; Wilck MB; Langston AA; Chu AH; Wloch MK; Guterwill DF; Smith LR; Rolland AP; Kenney RT
    Lancet Infect Dis; 2012 Apr; 12(4):290-9. PubMed ID: 22237175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada.
    Ladogana A; Puopolo M; Croes EA; Budka H; Jarius C; Collins S; Klug GM; Sutcliffe T; Giulivi A; Alperovitch A; Delasnerie-Laupretre N; Brandel JP; Poser S; Kretzschmar H; Rietveld I; Mitrova E; Cuesta Jde P; Martinez-Martin P; Glatzel M; Aguzzi A; Knight R; Ward H; Pocchiari M; van Duijn CM; Will RG; Zerr I
    Neurology; 2005 May; 64(9):1586-91. PubMed ID: 15883321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc as adjunct treatment in infants aged between 7 and 120 days with probable serious bacterial infection: a randomised, double-blind, placebo-controlled trial.
    Bhatnagar S; Wadhwa N; Aneja S; Lodha R; Kabra SK; Natchu UC; Sommerfelt H; Dutta AK; Chandra J; Rath B; Sharma M; Sharma VK; Kumari M; Strand TA
    Lancet; 2012 Jun; 379(9831):2072-8. PubMed ID: 22656335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial.
    Marty FM; Ljungman P; Papanicolaou GA; Winston DJ; Chemaly RF; Strasfeld L; Young JA; Rodriguez T; Maertens J; Schmitt M; Einsele H; Ferrant A; Lipton JH; Villano SA; Chen H; Boeckh M;
    Lancet Infect Dis; 2011 Apr; 11(4):284-92. PubMed ID: 21414843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral doxycycline for the prevention of postoperative trachomatous trichiasis in Ethiopia: a randomised, double-blind, placebo-controlled trial.
    Habtamu E; Wondie T; Aweke S; Tadesse Z; Zerihun M; Gashaw B; Roberts CH; Kello AB; Mabey DCW; Rajak SN; Callahan EK; Macleod D; Weiss HA; Burton MJ
    Lancet Glob Health; 2018 May; 6(5):e579-e592. PubMed ID: 29653629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial.
    Taylor MJ; Makunde WH; McGarry HF; Turner JD; Mand S; Hoerauf A
    Lancet; 2005 Jun 18-24; 365(9477):2116-21. PubMed ID: 15964448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline for the treatment of nodding syndrome: a randomised, placebo-controlled, phase 2 trial.
    Idro R; Ogwang R; Anguzu R; Akun P; Ningwa A; Abbo C; Giannoccaro MP; Kubofcik J; Mwaka AD; Nakamya P; Opar B; Taylor M; Nutman TB; Elliott A; Vincent A; Newton CR; Marsh K
    Lancet Glob Health; 2024 Jul; 12(7):e1149-e1158. PubMed ID: 38754459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.